Which One Would be supreme gem? – Physicians Realty Trust (DOC), Diebold Nixdorf, Incorporated (DBD)

The shares of Physicians Realty Trust have increased by more than 17.90% this year alone. The shares recently went up by 1.83% or $0.34 and now trades at $18.90. The shares of Diebold Nixdorf, Incorporated (NYSE:DBD), has jumped by 185.14% year to date as of 11/26/2019. The shares currently trade at $7.10 and have been able to report a change of -9.55% over the past one week.

The stock of Physicians Realty Trust and Diebold Nixdorf, Incorporated were two of the most active stocks on Tuesday. Investors seem to be very interested in what happens to the stocks of these two companies but do investors favor one over the other? We will analyze the growth, profitability, risk, valuation, and insider trends of both companies and see which one investors prefer.

Next 5Y EPS Growth: 9.70% versus 3.00%

When a company is able to grow consistently in terms of earnings at a high compound rate have the highest likelihood of creating value for its shareholders over time. Analysts have predicted that DOC will grow it’s earning at a 9.70% annual rate in the next 5 years. This is in contrast to DBD which will have a positive growth at a 3.00% annual rate. This means that the higher growth rate of DOC implies a greater potential for capital appreciation over the years.

Profitability and Returns

Growth alone cannot be used to see if the company will be valuable. Shareholders will be the losers if a company invest in ventures that aren’t profitable enough to support upbeat growth. In order for us to accurately measure profitability and return, we will be using the EBITDA margin and Return on Investment (ROI), which balances the difference in capital structure. DOC has an EBITDA margin of 63.87%, this implies that the underlying business of DOC is more profitable. The ROI of DOC is 1.20% while that of DBD is -18.00%. These figures suggest that DOC ventures generate a higher ROI than that of DBD.

Cash Flow

The value of a stock is ultimately determined by the amount of cash flow that the investors have available. Over the last 12 months, DOC’s free cash flow per share is a positive -0, while that of DBD is positive 1.43.


DOC currently trades at a forward P/E of 59.43, a P/B of 1.48, and a P/S of 8.69 while DBD trades at a forward P/E of 8.09, and a P/S of 0.12. This means that looking at the earnings, book values and sales basis, DOC is the cheaper one. It is very obvious that earnings are the most important factors to investors, thus analysts are most likely to place their bet on the P/E.

Analyst Price Targets and Opinions

The mistake some people make is that they think a cheap stock has more value to it. In order to know the value of a stock, there is need to compare its current price to its likely trading price in the future. The price of DOC is currently at a 0.8% to its one-year price target of 18.75. Looking at its rival pricing, DBD is at a -45.38% relative to its price target of 13.00.

When looking at the investment recommendation on say a scale of 1 to 5 (1 being a strong buy, 3 a hold, and 5 a sell), DOC is given a 2.40 while 2.20 placed for DBD. This means that analysts are more bullish on the outlook for DOC stocks.

Insider Activity and Investor Sentiment

Short interest or otherwise called the percentage of a stock’s tradable shares currently being shorted is another data that investors use to get a handle on sentiment. The short ratio for DOC is 3.30 while that of DBD is just 9.01. This means that analysts are more bullish on the forecast for DOC stock.


The stock of Physicians Realty Trust defeats that of Diebold Nixdorf, Incorporated when the two are compared, with DOC taking 5 out of the total factors that were been considered. DOC happens to be more profitable, generates a higher ROI, has higher cash flow per share, higher liquidity and has a lower financial risk. When looking at the stock valuation, DOC is the cheaper one on an earnings, book value and sales basis. Finally, the sentiment signal for DOC is better on when it is viewed on short interest.